Page 776 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 46 Autoimmune Hemolytic Anemia 662.e1

REFERENCES 28. Gómez-Puerta JA, Martín H, Amigo MC, et al: Long-term follow-up in
128 patients with primary antiphospholipid syndrome: do they develop
1. Dacie SJ: The immune haemolytic anaemias: a century of exciting pro- lupus? Medicine (Baltimore) 84:225, 2005.
gress in understanding. Br J Haematol 114:770, 2001. 28a. Giannadaki E, Potamianos S, Roussomoustakaki M, et al: Autoimmune
2. Packman CH: Hemolytic anemia due to warm autoantibodies. Blood Rev hemolytic anemia and positive Coombs test associated with ulcerative
22:17, 2008. colitis. Am J Gastroenterol 92(10):1872–1874, 1997.
3. Garratty G: Immune hemolytic anemia-a primer. Semin Hematol 42:119, 29. Sanz J, Arriaga F, Montesinos P, et al: Autoimmune haemolytic anemia
2005. following allogeneic hematopoietic stem cell transplantation in adult
4. Petz LD: Immune hemolysis associated with transplantation. Semin patients. Bone Marrow Transplant 39:555, 2007.
Hematol 42:145, 2005. 30. Dearden C, Wade R, Else M, et al: The prognostic significance of a posi-
5. Pirofsky B: Clinical aspects of autoimmune hemolytic anemia. Semin tive direct antiglobulin test in chronic lymphocytic leukemia: A beneficial
Hematol 13:251, 1976. effect of the combination of fludarabine and cyclophosphamide on the
6. Berentsen S, Ulvestad E, Langholm R, et al: Primary chronic cold incidence of hemolytic anemia. Blood 111:1820, 2007.
agglutinin disease: a population based clinical study of 86 patients. 31. Chao TC, Chen CY, Yang YH, et al: Chronic hepatitis C virus infection
Haematologica 91:460, 2006. associated with primary warm-type autoimmune hemolytic anemia. J
7. King KE, Ness PM: Treatment of autoimmune hemolytic anemia. Semin Clin Gastroenterol 33:232, 2001.
Hematol 42:131, 2005. 32. Kulpa J, Skrabs C, Simanek R, et al: Probability of remaining in unsus-
8. Lechner K, Jäger U: How I treat autoimmune haemolytic anemias in tained complete remission after steroid therapy withdrawal in patients
adults. Blood 116:1831, 2010. with primary warm-antibody reactive autoimmune hemolytic anemia.
9. Aladjidi N, Leverger G, Leblanc T, et al: New insights into childhood Wien Klin Wochenschr 128:234, 2016.
autoimmune hemolytic anemia: a French national observational study 33. Barcellini W, Zaja F, Zaninoni A, et al: Low-dose rituximab in adult
of 265 children. Haematologica 96:655, 2011. patients with idiopathic autoimmune hemolytic anemia: clinical efficacy
10. Michel M, Chanet V, Dechartres A, et al: The spectrum of Evans and biologic studies. Blood 119:3691–3697, 2012.
syndrome in adults: new insight into the disease based on the analysis 34. Birgens H, Frederiksen H, Hasselbalch HC, et al: A phase III random-
of 68 cases. Blood 114:3167, 2009. ized trial comparing glucocorticoid monotherapy versus glucocorticoid
11. Brodsky RA: Complement in hemolytic anemia. Blood 126:2459, 2015. and rituximab in patients with autoimmune haemolytic anaemia. Br J
12. Berentsen S: Role of complement in autoimmune hemolytic anemia. Haematol 163:393–399, 2013.
Transfus Med Hemother 42:303, 2015. 35. Dierickx D, Kentos A, Delannoy A: The role of rituximab in adults with
13. Garratty G: The James Blundell Award Lecture 2007: Do we really warm antibody autoimmune hemolytic anemia. Blood 125:3223, 2015.
understand immune red cell destruction? Transfusion Med 18:321, 2008. 36. Chertkow G, Dacie JV: Results of splenectomy in auto-immune haemo-
14. Arndt PA, Leger RM, Garratty G: Serologic findings in autoimmune lytic anaemia. Br J Haematol 2:237, 1956.
hemolytic anemia associated with immunoglobulin M warm autoanti- 37. Coon WW: Splenectomy in the treatment of hemolytic anemia. Arch
bodies. Transfusion 49:2352, 2009. Surg 120:625, 1985.
15. Sokol RJ, Booker DJ, Stamps R, et al: Autoimmune hemolytic anemia 38. Allgood JW, Chaplin H, Jr: Idiopathic acquired autoimmune hemolytic
caused by warm-reacting IgM-class antibodies. Immunohematol 14:53, anemia. A review of forty-seven cases treated from 1955 through 1965.
1998. Am J Med 43:254, 1967.
16. Barcellini W: New insights in the pathogenesis of autoimmune hemolytic 39. Reynaud Q, Durieu I, Dutertre M, et al: Efficacy and safety of ritux-
anemia. Transfus Med Hemother 42:287, 2015. imab in auto-immune hemolytic anemia: a meta-analysis of 21 studies.
17. Barros MM, Blajchman MA, Bordin JO: Warm autoimmune haemolytic Autoimmun Rev 14:304, 2015.
anemia: Recent progress in understanding the immunobiology and the 40. D’Arena G, Laurenti L, Capalbo S, et al: Rituximab therapy for chronic
treatment. Transfus Med Rev 24:195, 2010. lymphocytic leukemia-associated autoimmune hemolytic anemia. Am J
18. Silberstein LE, Litwin S, Carmack CE: Relationship of variable region Hematol 81:598, 2006.
genes expressed by a human B cell lymphoma secreting pathologic anti- 41. Hallek M, Cheson BD, Catovsky D, et al: Guidelines for the diagnosis
Pr2 erythrocyte autoantibodies. J Exp Med 169:1631, 1989. and treatment of chronic lymphocytic leukemia: a report from the
19. Arthold C, Skrabs C, Mitterbauer-Hohendanner G, et al: Cold antibody International Workshop on Chronic Lymphocytic Leukemia updating
autoimmune hemolytic anemia and lymphoproliferative disorders: a the National Cancer Institute-Working Group 1996 guidelines. Blood
retrospective study of 20 patients including clinical, hematological and 111:5446, 2008.
TM
molecular findings. Wien Klin Wochenschr 126:376, 2014. 42. Montillo M, O’Brien S, Tedeschi A, et al: RESONATE study of
20. Michaux L, Dierlamm J, Wlodarska L, et al: Trisomy 3q11-q29 is recur- Ibrutinib vs Ofatumumab in relapsed/refractory chronic lymphocytic
rently observed in B-cell non-Hodgkin’s lymphomas associated with cold leukemia/small lymphocytic lymphoma, including a case report. Blood
agglutinin syndrome. Ann Hematol 76:201, 1998. 124:5654, 2014.
21. Barcellini W, Fattizzo B, Zaninoni A, et al: Clinical heterogeneity and 43. Roumier M, Loustau V, Guillaud C, et al: Characteristics and outcome
predictors of outcome in primary autoimmune hemolytic anemia: a of warm autoimmune haemolytic anemia in adults: new insights based
GIMEMA study of 308 patients. Blood 124:2930, 2014. on a single-center experience with 60 patients. Am J Hematol 89:E150,
22. Ramagopalan SV, Wotton CJ, Handel AE, et al: Risk of venous thrombo- 2014.
embolism in people admitted to hospital with selected immune-mediated 44. Berentsen S, Randen U, Vågan AM, et al: High response rate and
diseases: record-linkage study. BMC Med 9:1, 2011. durable remissions following fludarabine and rituximab combination
23. Garratty G: Immune hemolytic anemia associated with negative routine therapy for chronic cold agglutinin disease. Blood 2010:3180, 2010.
serology. Semin Hematol 42:156, 2005. 45. Gupta N, Wang ES: Long-term response of refractory primary cold
23a. Petz LD, Garraty G: Immune haemolytic anemias, ed 2, Philadelphia, agglutinin disease to eculizumab therapy. Ann Hematol 93:343, 2014.
2004, Churchill Livingstone. 46. Röth A, Bommer M, Hüttmann A, et al: Complement inhibition with
24. Mayer B, Yürek S, Kiesewetter H, et al: Mixed-type autoimmune hemo- eculizumab in patients with cold agglutinin disease (CAD): results from
lytic anemia: differential diagnosis and a critical review of reported cases. a prospective phase II trial (DECADE trial). Blood 126:274, 2015.
Transfusion 48:2229, 2008. 47. Shi J, Rose EL, Singh A, et al: TNT003, an inhibitor of the serine pro-
25. Berentsen S: Role of Complement in Autoimmune Hemolytic Anemia. tease C1s, prevents complement activation induced by cold agglutinins.
Transfus Med Hemother 42(5):303–310, 2015. doi: 10.1159/000438964. Blood 123:4015, 2014.
26. Teachey DT, Seif AE, Grupps SA: Advances in the management and 48. Jäger U, Gilbert JC, Panicker S, et al: The anti C1S complement anti-
understanding of autoimmune lymphoproliferative syndrome (ALPS). body TNT009 induces rapid complete remissions of anaemia in patients
Br J Haematol 148:205, 2010. with primary cold agglutinin disease. Annual Congress of the European
27. Kokori SI, Ioannidis JP, Voulgarelis M, et al: Autoimmune hemolytic Hematology Association 2016, late breaking abstract # 2237.
anemia in patients with systemic lupus erythematosus. Am J Med
108:198, 2000.